Siemens Healthineers Cuts 2026 Outlook on China Woes
Siemens Healthineers lowered its 2026 revenue outlook to 4.5-5.0% amid China price pressures. The firm also cut earnings guidance and may spin off diagnostics.
Xurve View
Insights:
Xurve View
SIEMENS HEALTHINEERS AG lowered its 2026 revenue growth forecast to 4.5%–5.0% following a 3.3% share price drop. The revision from the previous 5%–6% range follows a 6.5% revenue decline in the diagnostics division to 985 million euros. Reduced EPS guidance and a potential diagnostics spin-off reflect investor concerns over structural headwinds.
